Junius Daniel M

Avg. Two Year Performance

55% Avg. Purchase Return
24% Compound
10% Avg. Sale Return
5% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return4%11%(3%)31%55%
Purchase Success Rate2 of 53 of 52 of 54 of 53 of 5
Average Sale Return1%< 1%9%15%10%
Sale Success Rate9 of 2313 of 2316 of 2316 of 2316 of 23
»

Executive VP, CFO, & Treasurer:

Holdings: 17.07K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Diagnostic Substances

Director:

Holdings: 3.04K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Biotechnology

Director:

Holdings: 184.99K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Biotechnology

Director:

Holdings: 98.46K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Biotechnology

Director:

Holdings: shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--